← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
2 ta ish
Ish: Comment on “Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study”